Cytotoxic drugs and the CD95 pathway

Erstveröffentlichung
1999Authors
Friesen, C
Fulda, S
Debatin, Klaus-Michael
Beitrag zu einer Konferenz
Published in
Leukemia ; 13 (1999), 11. - S. 1854-1858. - ISSN 0887-6924
Link to publication
https://dx.doi.org/10.1038/sj.leu.2401333Institutions
UKU. Klinik für Kinder- und JugendmedizinConference
6th Workshop of the Cooperative-Study-Group-Cellular-Resistance (CSG-CR) on Apoptosis and Chemotherapy Resistance, 1997-10, Linz, Austria
Subject headings
[Free subject headings]: apoptosis | CD95 | CD95 ligand | cytotoxic drugs | chemosensitivity | resistance | chemotherapy-induced apoptosis | apo-1/fas receptor/ligand system | cell-surface antigen | fas ligand | leukemia-cells | wild-type | mitochondrial control | deficient activation | monoclonal-antibody | neuroblastoma-cells[DDC subject group]: DDC 610 / Medicine & health